393 related articles for article (PubMed ID: 27704245)
21. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
[TBL] [Abstract][Full Text] [Related]
22. Early proactive management of vestibular schwannomas in neurofibromatosis type 2.
Brackmann DE; Fayad JN; Slattery WH; Friedman RA; Day JD; Hitselberger WE; Owens RM
Neurosurgery; 2001 Aug; 49(2):274-80; discussion 280-3. PubMed ID: 11504103
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
24. Audiovestibular Characteristics of Small Cochleovestibular Schwannomas in Neurofibromatosis Type 2.
Holliday MA; Kim HJ; Zalewski CK; Wafa T; Dewan R; King KA; Brewer CC; Butman JA; Asthagiri AR
Otolaryngol Head Neck Surg; 2014 Jul; 151(1):117-24. PubMed ID: 24718755
[TBL] [Abstract][Full Text] [Related]
25. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
26. A clinical study of vestibular schwannomas in type 2 neurofibromatosis.
Kishore A; O'Reilly BF
Clin Otolaryngol Allied Sci; 2000 Dec; 25(6):561-5. PubMed ID: 11122300
[TBL] [Abstract][Full Text] [Related]
27. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
28. Outcome from surgery for vestibular schwannomas in children.
MacNally SP; Rutherford SA; King AT; Freeman S; Thorne J; Mawman D; O'Driscoll MP; Evans DG; Ramsden RT
Br J Neurosurg; 2009 Jun; 23(3):226-31. PubMed ID: 19533454
[TBL] [Abstract][Full Text] [Related]
29. Hearing changes after diagnosis in neurofibromatosis type 2.
Masuda A; Fisher LM; Oppenheimer ML; Iqbal Z; Slattery WH;
Otol Neurotol; 2004 Mar; 25(2):150-4. PubMed ID: 15021775
[TBL] [Abstract][Full Text] [Related]
30. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
31. Cochlear implants to treat deafness caused by vestibular schwannomas.
Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
[TBL] [Abstract][Full Text] [Related]
32. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
33. Hearing preservation in neurofibromatosis type 2.
Slattery WH; Brackmann DE; Hitselberger W
Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2.
Hochart A; Gaillard V; Baroncini M; André N; Vannier JP; Vinchon M; Dubrulle F; Lejeune JP; Vincent C; Nève V; Sudour Bonnange H; Bonne NX; Leblond P
J Neurooncol; 2015 Sep; 124(2):229-36. PubMed ID: 26022982
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2: Hearing preservation and rehabilitation.
Jia H; El Sayed MME; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Neurochirurgie; 2018 Nov; 64(5):348-354. PubMed ID: 30314805
[TBL] [Abstract][Full Text] [Related]
36. A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas.
Chung LK; Nguyen TP; Sheppard JP; Lagman C; Tenn S; Lee P; Kaprealian T; Chin R; Gopen Q; Yang I
World Neurosurg; 2018 Jan; 109():47-58. PubMed ID: 28882713
[TBL] [Abstract][Full Text] [Related]
37. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
Rosahl S; Bohr C; Lell M; Hamm K; Iro H
Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
[TBL] [Abstract][Full Text] [Related]
39. Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.
Chen LH; Zhang HT; Xu RX; Zhang L; Li WD; Sun K
Medicine (Baltimore); 2018 Apr; 97(17):e0270. PubMed ID: 29702972
[TBL] [Abstract][Full Text] [Related]
40. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
